13058-77-0 Usage
Description
8-CHLORO-[1,7]NAPHTHYRIDINE is a chemical compound that belongs to the naphthyridine family, which are heterocyclic aromatic compounds. This specific compound features a chlorine atom attached to the 8th carbon of the naphthyridine ring, providing unique chemical and biological properties that make it a valuable tool in various applications.
Uses
Used in Pharmaceutical Industry:
8-CHLORO-[1,7]NAPHTHYRIDINE is used as a building block for the synthesis of various pharmaceutical compounds, particularly for the development of anti-bacterial and anti-cancer agents. The presence of the chloro group in the compound can enhance its chemical and biological properties, making it a promising candidate for drug discovery and development.
Used in Materials Science:
8-CHLORO-[1,7]NAPHTHYRIDINE has been studied for its potential applications in materials science, where its unique properties can contribute to the development of new materials with specific characteristics.
Used in Biological Imaging:
8-CHLORO-[1,7]NAPHTHYRIDINE is also considered as a fluorescent probe in biological imaging, where its properties can be utilized for visualizing and studying biological processes and structures.
Check Digit Verification of cas no
The CAS Registry Mumber 13058-77-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,0,5 and 8 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 13058-77:
(7*1)+(6*3)+(5*0)+(4*5)+(3*8)+(2*7)+(1*7)=90
90 % 10 = 0
So 13058-77-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H5ClN2/c9-8-7-6(3-5-11-8)2-1-4-10-7/h1-5H
13058-77-0Relevant articles and documents
-
Armarego,Batterham
, p. 750,751 (1966)
-
HETEROARYL COMPOUNDS AS CXCR4 INHIBITORS, COMPOSITION AND METHOD USING THE SAME
-
, (2019/04/16)
The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to the CXCR4 pathway.
